$IDXG 8-K SEC Filings

Filed On	Filing
15 Oct 2026	8-K: Results of Operations and Financial Condition Interpace Biosciences Announces Preliminary Unaudited Third Quarter 2026 Revenue
27 Aug 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Regulation FD Disclosure
21 Aug 2026	8-K: Submission of Matters to a Vote of Security Holders
12 Aug 2026	8-K: Results of Operations and Financial Condition
14 May 2026	8-K: Results of Operations and Financial Condition
01 Apr 2026	8-K: Results of Operations and Financial Condition
20 Jan 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
03 Dec 2025	8-K: Other Events
12 Nov 2025	8-K: Results of Operations and Financial Condition
08 Aug 2025	8-K: Results of Operations and Financial Condition
08 May 2025	8-K: Results of Operations and Financial Condition
01 May 2025	8-K: Costs Associated with Exit or Disposal Activities; Other Events
06 Mar 2025	8-K: Non-Reliance on Previously Issued Financial Statements
27 Jan 2025	8-K: Costs Associated with Exit or Disposal Activities; Other Events
21 Jan 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
10 Jan 2025	8-K: Other Events
13 Nov 2024	8-K: Submission of Matters to a Vote of Security Holders
06 Nov 2024	8-K: Results of Operations and Financial Condition
15 Oct 2024	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +3 more
02 Aug 2024	8-K: Results of Operations and Financial Condition

Comments